Ewing sarcoma and related FET family translocation-associated round cell tumors: A century of clinical and scientific progress
- PMID: 35443099
- PMCID: PMC9197982
- DOI: 10.1002/gcc.23050
Ewing sarcoma and related FET family translocation-associated round cell tumors: A century of clinical and scientific progress
Abstract
The year 2021 marked the centenary of the first publication of a cancer termed diffuse endothelioma of bone by James Ewing. Its unique features were apparent even in the first case series he described. This new diagnosis was clearly distinct from osteogenic sarcoma and myeloma, which were already well recognized at the time. We undertake this summary to better understanding Ewing sarcoma, contrasting the logarithmic evolution of the standard of care of systemic therapy for this and related diagnoses to the exponential understanding of the molecular biology of this family of tumors. We also outline in this manuscript how the finding of genomic relatives within Ewing sarcoma itself and related tumors, first noted nearly 40 years ago, helps us appreciate the need to find therapeutic plans that are specific for each small round blue cell tumor subtype. The advent of next generation sequencing regarding previously unknown small round blue cell tumor subtypes in many ways puts us back in the shoes of James Ewing in 1921, searching anew for clues leading to better treatments for increasingly rare cancer subsets.
Keywords: BCOR::CCNB3; CIC::DUX4; Ewing sarcoma; FET sarcoma; small round cell tumor; systemic therapy; translocation.
© 2022 Wiley Periodicals LLC.
Figures
References
-
- Ewing J. Diffuse endothelioma of bone. Proc New York Pathol Soc. 1921. 1921;21(New Series):17–24.
-
- Scanlon PW. Radiotherapy of Ewing’s sarcoma. Am J Roentgenol Radium Ther Nucl Med. Mar 1962;87:504–10. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
